Informations sur le produit
Anilopam is an analog that has been identified as a potential anticancer agent. It works by inhibiting protein kinases, which are enzymes that play a crucial role in the growth and proliferation of cancer cells. Anilopam has been shown to inhibit the activity of several tumor-associated kinases, including those involved in cell cycle regulation and apoptosis. This medicinal compound has demonstrated potent antitumor activity in human cancer cell lines and has also shown promising results in preclinical studies. Anilopam is excreted primarily in urine and may have potential as a urinary biomarker for cancer diagnosis or monitoring treatment response. Its ability to inhibit kinase activity makes it a promising therapeutic option for the treatment of various types of cancers.
Propriétés chimiques
Question d’ordre technique à propos de: Anilopam
Veuillez plutôt utiliser le panier afin de demander un devis ou passer commande